News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
-
AB2 Bio receives USD 30 million from Nippon Shinyaku
startupticker.ch
DTN Highlights
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
A $16M round and key milestones strengthen Sunflower Labs’s position
Sunflower Labs, creator of the Beehive autonomous security drone system has obtained nationwide FAA approval to operate beyond visual line of sight (BVLOS) across the…
startupticker.ch
startupticker.ch: A $16M round and key milestones strengthen Sunflower Labs’s position- Sunflower Labs won FAA nationwide approval for autonomous BVLOS drone flights over people and vehicles without case-by-case approval.
- Sunflower Labs closed $16M Series B funding led by Sequoia Capital to expand AI development and operations globally.
- Sunflower Labs launched an online tool for customers to preview Beehive system coverage on their property before purchase.
-
$150 million to scale DEXTER the surgical robot across the US
Distalmotion, the developer of surgical robot DEXTER which is designed to empower access to the benefits of robotic surgery in outpatient sites of care, has…
startupticker.ch
startupticker.ch: $150 million to scale DEXTER the surgical robot across the US- Distalmotion raised $150M Series G funding led by Revival Healthcare Capital to accelerate US adoption of its DEXTER surgical robot.
- DEXTER has treated nearly 3,000 patients in Europe and US with a compact design requiring no operating room modifications.
- Chas McKhann, ex-CEO of two public medical device companies, joined as Executive Chairman to lead ASC market expansion.
-
Albatross raises CHF 9.7 million to reinvent product discovery for the web
Former Amazon AI leaders raise CHF 9.7 m to deploy AI that understands user intent in real time, transforming how they discover products and content…
startupticker.ch
startupticker.ch: Albatross raises CHF 9.7 million to reinvent product discovery for the web- Albatross raised €10.5M for real-time AI that adapts to user intent, replacing static recommendation systems.
- Founded by ex-Amazon AI leaders, Albatross serves billions of live events monthly with integration in under seven weeks.
- Early pilots showed triple-digit engagement gains, positioning real-time personalization as the next AI evolution step.
-
Indivi secures CHF 15 million
TechBio company Indivi has closed a CHF15 million investment round led by Ava Investors to accelerate the validation and deployment of precision medicine tools in…
startupticker.ch
startupticker.ch: Indivi secures CHF 15 million- Indivi raised CHF15 million from Ava Investors to develop digital biomarkers for accelerating Alzheimer's drug development.
- The company's smartphone tools capture motor, cognitive, vision, and voice data for regulatory trials and clinical use.
- Indivi plans a 2026 trial to identify biomarkers for amyloid-depleting Alzheimer's therapies.
-
CHF 172 million for growth start-ups
Following the first closing of the Swisscanto (CH) Private Equity Switzerland Growth II fund, managed by Zürcher Kantonalbank, investment activities will now commence. The majority…
startupticker.ch
startupticker.ch: CHF 172 million for growth start-ups- Swisscanto Private Equity Switzerland Growth II raised CHF 171.65 million from 45 investors in eight months.
- The fund invests in Swiss growth companies with innovative tech in health, industry, and data services.
- Zürcher Kantonalbank's PE programs manage nearly CHF 500 million across three funds, including a decarbonisation fund.
-
NNAISENSE gets acquired by Germany asset management firm
Based in Lugano, NNAISENSE has built a generative AI framework for financial markets to enable the prediction of coherent market scenarios across multiple asset classes,…
startupticker.ch
startupticker.ch: NNAISENSE gets acquired by Germany asset management firm- ACATIS Investment KVG acquired NNAISENSE to gain exclusive access to its Large Investing Model for predicting financial market scenarios.
- NNAISENSE's LIM, developed by DeepMind's Alex Graves, analyzes multiple asset classes and macroeconomic, fundamental, and alternative data.
- NNAISENSE maintains its Lugano headquarters and will focus exclusively on developing the LIM for ACATIS's portfolio management.
-
Delvitech closes USD 40 million Series B round to accelerate global growth
Delvitech, specializing in the development of AI-native Automated Optical Inspection (AOI) solutions for electronics, closed a Series B investment round of USD 40 million. Delvitech…
startupticker.ch
startupticker.ch: Delvitech closes USD 40 million Series B round to accelerate global growth- Delvitech raised $40M in Series B funding to expand its AI-native optical inspection platform globally, with an Indian plant planned for 2026.
- Delvitech's neural networks and Swiss hardware enable predictive quality control that anticipates errors rather than detecting them in PCB components.
- Delvitech projects 400% sales growth by end of 2025 and added neural networks pioneer Prof.
-
Wellcome awards CHF 14 million for BioVersys’ BV100 Phase 2b study
BioVersys’ lead asset BV100, an innovative anti-infective developed for hospital infections caused by Acinetobacter baumannii, including carbapenem resistant strains (CRAB), has been selected to participate…
startupticker.ch
startupticker.ch: Wellcome awards CHF 14 million for BioVersys’ BV100 Phase 2b study- BioVersys' BV100, a novel IV rifabutin formulation, selected for ADVANCE-ID Phase 2b trial targeting carbapenem-resistant Acinetobacter baumannii.
- Wellcome funding of SGD 22 million enables first sponsor-driven ADVANCE-ID trial, expanding enrollment to 90 and adding combination therapy arms.
- First patient dosing expected H1 2026 with interim data H2 2026, supporting BV100's Phase 3 program for US, European, and Chinese submissions.
-
AstraZeneca acquires SixPeaks for up to USD 300 million
Following an initial investment of USD 15 million in 2024, AstraZeneca has acquired Basel-based SixPeaks Bio AG. SixPeaks is investigating potential therapies for weight-management with…
startupticker.ch
startupticker.ch: AstraZeneca acquires SixPeaks for up to USD 300 million- AstraZeneca acquired Basel-based SixPeaks Bio for up to $300M, exercising an option after a $15M 2024 investment.
- SixPeaks develops activin IIA/B receptor antibodies to preserve muscle mass, addressing a GLP-1 drug limitation.
- SixPeaks created a first-in-class GLP-1 antibody conjugate combining weight loss with muscle preservation.
-
Positrigo on a growth momentum in the US
One year following the acquisition of its first customer in the US market, Positrigo continues to strengthen its position in America. The company has installed…
startupticker.ch
startupticker.ch: Positrigo on a growth momentum in the US- Positrigo's FDA-cleared NeuroLF brain PET scanner is rapidly expanding in the US market with multiple installations.
- New Alzheimer's disease-modifying therapies are driving demand for brain PET scans, creating market opportunities.
- Positrigo expanded operations with new executives and board members, strengthening European distribution in Spain and France.
-
CDR-Life to receive up to CHF 456 million in license agreement with Boehringer Ingelheim
Building on their longstanding partnership in retinal health, Boehringer Ingelheim and CDR-Life, Inc. have entered a new global licensing agreement to develop CDR-Life’s antibody-based molecule…
startupticker.ch
startupticker.ch: CDR-Life to receive up to CHF 456 million in license agreement with Boehringer Ingelheim- Boehringer Ingelheim licensed CDR111, a trispecific antibody T-cell engager, with up to CHF 456M in milestone and royalty payments.
- CDR111 selectively depletes dysregulated B cells to reset immunity, potentially treating lupus, MS, and arthritis.
- The partnership expands prior collaboration on a Phase 2 geographic atrophy treatment, validating CDR-Life's platform.
-
CHF 28 million for Switzerland’s new Bitcoin treasury company
Future Holdings AG, Switzerland’s premier Bitcoin treasury company, has closed a CHF 28 million strategic funding round anchored by cornerstone investors Fulgur Ventures, Nakamoto, and…
startupticker.ch
startupticker.ch: CHF 28 million for Switzerland’s new Bitcoin treasury company- Future Holdings AG raised CHF 28 million from investors including Fulgur Ventures, Nakamoto, and TOBAM.
- The Swiss company offers institutional Bitcoin exposure in CHF with treasury, research, and advisory services.
- Future is led by CEO Sebastien Hess and co-founders from Syz Capital, Relai, and Blockstream.
-
Read more: Swiss-Built Precision Powers NASA’s Return to the MoonOn April 1, 2026, NASA’s Artemis II mission launched four astronauts toward the Moon, marking the first crewed flight beyond low Earth orbit since 1972.…
-
Read more: Project Switzerland: 10 Scale-ups selected to join the ranks of Switzerland’s global market leadersToday marks another milestone for Project Switzerland, the national Scale-up initiative initiated by Deep Tech Nation Switzerland. 10 high-growth companies have been selected for the…
-
Read more: 2026 European Deep Tech Report: ETH Zurich and EPFL Lead the World in Deep Tech Founder and Spinout CreationThe 2026 European Deep Tech Report, published by Lakestar, Walden Catalyst, and Dealroom, confirms what the data has been building toward for years: Switzerland’s deep…
-
Read more: Swiss Deep Tech in 12 Charts: The 2026 Facts & Figures UpdateDeep Tech Nation Switzerland has refreshed its Facts & Figures page with 2026 data covering venture capital flows, startup creation, sector momentum, and founder profiles.…
-
Read more: Amazon Acquires RIVR: How an ETH Zurich Lab Built the Robot That Delivers Your PackagesWhen the world’s largest logistics company needs to solve its hardest physical problem, it looks to Zurich. On March 19, 2026, Amazon confirmed the acquisition…
-
Read more: Switzerland Is Building a Scale-Up Ecosystem. Here Is What That Looks Like.Switzerland’s early-stage startup infrastructure is among the most effective in Europe. The Swiss Venture Capital Report 2026 confirms a 24% rebound in total venture capital…
-
Read more: Pureos: At Face ValueThe Trained Gut Dominik Escher, Founding Partner at Pureos Bioventures, is in the business of organs. More specifically, he’s in the business of funding the…
-
Read more: Pureos: Backed to the FutureEscher’s passion for science and the potential to help patients is as deeply ingrained in his DNA as his entrepreneurial spirit. It is no surprise…
-
Read more: Pureos Bioventures: A Matter of ScaleThere is a contradiction at the heart of Swiss biotech that Dominik Escher has spent the better part of two decades trying to resolve. The…
-
Read more: Switzerland and the EU Just Signed Bilaterals III. Here Is Where the Ecosystem Stands TodayThe signing ceremony in Brussels on 2 March 2026 was the formal close of a process that began in earnest in March 2024. Swiss President…
-
Read more: Switzerland Returns to SusHi Tech with 10 Startups and a Champion’s MandateWhen the Swisstech Pavilion, organized by Swissnex, took home the SusHi Tech Award 2025 for Most Innovative Pavilion, it confirmed what Switzerland’s innovation institutions had…
-
Read more: 20 Reforms to Compete Globally: The Swiss Startup Agenda by SSASwitzerland’s startup ecosystem has reached a critical inflection point. While the country continues to lead Europe in per-capita spinout creation and deep tech innovation, structural…
